5/10
12:50 pm
xers
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/10
11:26 am
xers
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Low
Report
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
5/9
07:17 am
xers
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events [Yahoo! Finance]
Low
Report
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events [Yahoo! Finance]
5/9
07:00 am
xers
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
Low
Report
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
5/6
07:26 am
xers
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics [Yahoo! Finance]
Medium
Report
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics [Yahoo! Finance]
5/6
07:01 am
xers
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
Medium
Report
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
5/6
07:00 am
xers
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Low
Report
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
5/2
11:55 am
xers
Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock [Yahoo! Finance]
Low
Report
Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock [Yahoo! Finance]
5/2
07:13 am
xers
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 [Yahoo! Finance]
Medium
Report
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 [Yahoo! Finance]
5/2
07:00 am
xers
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
Medium
Report
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
4/5
11:43 am
xers
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions [Yahoo! Finance]
Low
Report
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions [Yahoo! Finance]
4/3
04:05 pm
xers
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/2
07:00 am
xers
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Medium
Report
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
3/30
01:33 am
xers
Xeris Biopharma: Checking-In On One Of My 'Top Ideas' [Seeking Alpha]
Low
Report
Xeris Biopharma: Checking-In On One Of My 'Top Ideas' [Seeking Alpha]
3/28
08:06 am
xers
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
Medium
Report
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
3/9
09:28 am
xers
Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results [Yahoo! Finance]
Medium
Report
Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results [Yahoo! Finance]
3/7
02:06 pm
xers
Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
Neutral
Report
Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
3/7
12:17 pm
xers
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
07:12 am
xers
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital [Yahoo! Finance]
High
Report
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital [Yahoo! Finance]
3/6
07:12 am
xers
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events [Yahoo! Finance]
High
Report
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events [Yahoo! Finance]
3/6
07:02 am
xers
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
High
Report
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
3/6
07:00 am
xers
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
High
Report
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
3/5
11:11 am
xers
Why Xeris (XERS) Might Surprise This Earnings Season [Yahoo! Finance]
Medium
Report
Why Xeris (XERS) Might Surprise This Earnings Season [Yahoo! Finance]
2/28
07:00 am
xers
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
Medium
Report
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024